Moderna
MRNA
#1187
Rank
ยฃ12.57 B
Marketcap
ยฃ32.67
Share price
7.48%
Change (1 day)
-47.86%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024ยฃ0.14 B3.95%
2023ยฃ0.13 B-50.15%
2022ยฃ0.27 B-85.7%
2021ยฃ1.90 B158.2%
2020ยฃ0.73 B369.18%
2019ยฃ0.15 B1011.49%
2018ยฃ14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
ยฃ0.86 Mยฃ6.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ14.45 Mยฃ88.44 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.09 Mยฃ0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.34 Mยฃ44.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ22.57 Mยฃ74.81 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ0.64 Mยฃ10.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ70.18 Mยฃ0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA